Saarland University Blood-Based MicroRNA Signatures Can Distinguish Individuals With Lung Cancer A retrospective cohort study uncovered microRNA signatures that could tell lung cancer patients apart from others, including patients with other, non-tumor lung conditions. BGI Launches New Sequencer as Customers Report Data From Earlier Instruments Premium At the ICG-13 conference, BGI previewed a high-throughput sequencer, MGISEQ-T7, that will be commercially available in 2019 and have a throughput of up to 20,000 genomes per year. New Technique Allows Sequencing of Short RNAs From Dried Blood Spots, Other Small Samples Premium Researchers have demonstrated that they can detect more miRNAs, as well as other small RNA molecules, by sequencing these samples rather than using microarrays. BGI, Hummingbird Diagnostics to Develop miRNA Tests for Neurodegenerative Disorders The partners will use Hummingbird's miRNA database and expertise in sample preparation as well as BGI's BGISEQ sequencer and analysis pipeline to develop targeted miRNA IVD assays. Hummingbird Diagnostics, Saarland University Form Biomarker Validation Partnership The partners plan to validate blood-based microRNAs as biomarkers for the early detection of pulmonary and neurodegenerative diseases. Dec 15, 2015 New Study Validates Blood-Based miRNA Biomarkers for Early Detection of Lung Cancer Jul 29, 2013 MicroRNA Expression Profiling Points to Possible Alzheimer's Signature in Blood Sep 4, 2012 German Epigenome Project to Generate 70 Reference Maps as Part of International Effort Premium Jul 14, 2009 Array Firms Debut New Products to Cash in on 'Lucrative' Sequence-Capture Market Premium Breaking News Biora Therapeutics Settles Claims of Misleading Genetic Testing Advertisements Genetic Overlap Between Schizophrenia, Cardiovascular Disease Risk Uncovered by GWAS Analysis Evvy Closes $14M Series A for Vaginal Microbiome Testing, Launches Add-on STI Screen Consanguinity Contributes to Common Disease Risk, Study Suggests Ginkgo Bioworks, Pfizer Ink RNA Drug Discovery Deal Worth up to $331M The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.